Article metrics

Download PDFPDF

Extended report
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: September 2016 to April 2024

AbstractFullPdf
Sep 2016592242163
Oct 2016728296334
Nov 201620210699
Dec 2016855229
Jan 2017858942
Feb 20173384234
Mar 20179197145
Apr 20171027681
May 2017322284
Jun 20174117053
Jul 201714514148
Aug 201720218436
Sep 201719317543
Oct 201717916376
Nov 201713412636
Dec 201713212824
Jan 201821219640
Feb 201815714135
Mar 201815413555
Apr 201815313033
May 201813111324
Jun 201811611125
Jul 201812511813
Aug 201810710333
Sep 201818918126
Oct 201823022234
Nov 201825425135
Dec 201820119612
Jan 201919918835
Feb 201918017132
Mar 201912411441
Apr 20191049819
May 201912712134
Jun 201911510321
Jul 201911310033
Aug 2019747034
Sep 20191099738
Oct 20191229924
Nov 201911710933
Dec 201911311033
Jan 202012311728
Feb 202012011029
Mar 202012210946
Apr 202014012444
May 20201039441
Jun 202018716136
Jul 202013713126
Aug 202014211744
Sep 202013512033
Oct 202013611925
Nov 202012111131
Dec 202019417042
Jan 202113912127
Feb 202120818163
Mar 202117816648
Apr 202117916149
May 202114614252
Jun 202115815874
Jul 202117817862
Aug 202112512553
Sep 202112112135
Oct 202117517242
Nov 202116115297
Dec 202115014039
Jan 202215114956
Feb 202215113764
Mar 202223623788
Apr 202221420243
May 202218818242
Jun 202214214940
Jul 202212310920
Aug 202215214024
Sep 202222421565
Oct 202218819770
Nov 2022291307105
Dec 2022989218
Jan 202312812237
Feb 202317116032
Mar 20231089134
Apr 202315514038
May 202311610823
Jun 202311610435
Jul 202310010034
Aug 2023787735
Sep 20231019635
Oct 20231159435
Nov 202317617530
Dec 202319813030
Jan 2024885515
Feb 20241109727
Mar 202416014272
Apr 202413412932
Total14089131644514